Cosmos Health Inc. (COSM): Cost of Revenue
$57.38M
Year ended 2025-12-31
$66.15M
Trailing 12 months to 2026-06-30
+8.9%
3-year compound annual growth
+3.9%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $57.38M | +14.5% | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | $50.12M | +2.2% | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | $49.03M | +10.4% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $44.39M | -7.3% | 2024-08-05, From 2022-01-01 |
| 2021-12-31 | $47.91M | +1.2% | 2023-04-12, From 2021-01-01 |
| 2020-12-31 | $47.35M | +31.5% | 2022-12-16, From 2020-01-01 |
| 2019-12-31 | $36.01M | +3.9% | 2021-04-15, From 2019-01-01 |
| 2018-12-31 | $34.68M | +23.6% | 2020-04-14, From 2018-01-01 |
| 2017-12-31 | $28.06M | +355.9% | 2019-04-18, From 2017-01-01 |
| 2016-12-31 | $6.15M | n/m | 2018-04-17, From 2016-01-01 |
| 2015-12-31 | $484.8K | n/a | 2017-04-17, From 2015-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | 2025-12-31 | $57.38M | +14.5% |
| DataMeds AI, Inc. (MEDS) | 2025-12-31 | $29.76M | +81.9% |
| Stemtech Corp (STEK) | 2025-12-31 | $566.9K | -57.3% |
| Nu Skin Enterprises, Inc. (NUS) | 2025-12-31 | $453.76M | -17.5% |
| HWH International Inc. (ESYN) | 2025-12-31 | $407.2K | -37.5% |
| Herbalife Ltd. (HLF) | 2025-12-31 | $1.11B | +0.9% |
| Cardinal Health Inc (CAH) | 2026-06-30 | $244.47B | +14.0% |
| Cencora, Inc. (COR) | 2025-09-30 | $309.85B | +9.1% |
| McKesson Corp (MCK) | 2026-03-31 | $388.88B | +12.5% |
Compare COSM, MEDS, STEK, NUS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗